Human monoclonal antibodies bind Crimean Congo Hemorrhagic Fever Virus antigens for diagnostic detection.
Matched antibody pairs enable electrochemiluminescent detection of soluble PD-L1, resolving interference from endogenous compounds and therapeutic agents.
Segmenting calcium ions into a separate liquid solvent prevents divalent metal ion-dependent deterioration of the lyophilized thromboplastin powder.
Segmented fusion proteins replace animal assays to improve neurotoxin sensitivity while maintaining simple cell-based test system complexity.
Matched monoclonal antibodies 6H9 and 8C9 detect MRJP4 via ELISA or colloidal gold strips, solving accuracy limits in perishable product assessment.
Single-domain antibody polypeptides reduce molecular weight to 15 kDa via VHH extraction, improving tissue penetration while maintaining binding specificity.
Fluorescently labeled aptamers quantify extracellular vesicles via fluorescence polarization, avoiding interference from free tumor markers in blood.
Silk fibroin matrix entrains Cage and Key proteins to resolve transduction complexity while maintaining shelf stability.
Engineered 3bgf antibodies resolve specificity trade-offs by targeting the SARS-CoV-2 spike protein receptor binding domain.
Portable blood pregnancy test kit uses a push button to release reagents, enabling accurate at-home hCG detection without lab equipment.
An ANTI-FLAG antibody detects Helicobacter pylori neutrophil-activating protein in test samples.
Anti-FcRH5 antibodies bind the Ig-like domain 9 epitope to enable targeted cancer therapy.
Modified CDR sequences in HER3 antibodies enable specific detection in formalin-fixed paraffin-embedded tissue samples.
A cytokeratin assay uses immobilized monoclonal antibodies to capture target proteins for detection.
Monoclonal antibodies enable specific detection of phosphinothricin-N-acetyl-transferase enzyme in plant tissues.
Measuring NT-TFPI2 polypeptide levels with specific antibodies resolves low CA125 sensitivity and specificity for ovarian clear cell adenocarcinoma.
Antagonist antibodies targeting the CEACAM1 IgV domain block homophilic interactions and restore anti-tumor immunity in cancer patients.
Supervised machine learning models analyze glycosylated peptide structures in liquid biopsy samples to identify disease indicators.
Engineered variable regions resolve BCMA binding complexity, enabling accurate cancer diagnosis via immunohistochemistry.
Optimized particle size and sugar concentration prevent agglutination, maintaining high sensitivity for procalcitonin quantification.
Controlled enzyme and pH conditions replace live pig breeding to determine egg viability rapidly without animal slaughter.
Mass spectrometry analysis identifies aggressive lipogenic phenotypes through specific lipid ratios, enabling precise treatment selection.
Surface-grafted hydrophilic polymer brushes on MIP nanoparticles resolve incompatibility with biological samples, enabling specific analyte detection.
Sandwich ELISA quantifies meningococcal serogroup X polysaccharides with 0.4 ng/ml detection limits, resolving excipient interference in multivalent vaccines.
Solid phase recesses catch nematodes, preventing anesthetic diffusion errors and ensuring accurate counting.
Antibodies target the OX40 C-terminus to resolve binding precision versus immune response reliability contradictions.
Protease digestion and affinity capture isolate Fc fragments to resolve signal-to-noise issues in antibody-drug conjugate transformation detection.
A composite SERS nano-particle captures circulating tumor cells using magnetic separation and surface-enhanced Raman scattering signals.
A lectin binds to alpha1-6 fucose sugar chains on urinary PSA to form a detectable complex.
Porous carrier matrices reduce sample and reagent volumes while maintaining detection reliability in dry chemistry instruments.
NCAM1, SSEA3, and CD340 markers isolate cardiomyocytes to resolve low purity from limited surface markers.
Soluble receptor binding ligands detect membrane receptors to select stem cells and reduce lymphoproliferative disorders in gene therapy.
Automated plant screening classifies chemical substances by site and mode of action using non-destructive imaging.
Integrated microfluidic channels measure hCG, FSH, and progesterone metabolites to differentiate pregnancy-related signals from non-pregnancy associated hCG.
A method measures T2R and T1R receptor expression to predict individual cannabis taste preferences.
Neu5Gc-sialylated antigens and specific antibodies detect early-stage cancer, resolving low sensitivity issues in current biomarker assays.
Segmented epitope binding and species-specific antibody selection resolve therapeutic interference to ensure reliable diagnostic results.
Photonic sensor arrays detect target analytes using enzymatic enhancement strategies for sensitive quantitation.
Measuring phospholipid acyl chain length changes in body fluids to detect tumor evolution and guide personalized treatment decisions.
Pooling mesenchymal stem cells from multiple donors reduces batch variability and immunogenicity while maintaining potency for consistent COVID-19 treatment.
Linking two antibody domains into a dimer reduces the dissociation constant, improving binding affinity for the GII/4 norovirus strain.
Anti-BK virus antibodies neutralize serotypes I through IV, resolving graft dysfunction risks in transplant patients.
Centrifugation removes cellular interference from whole blood, allowing accurate biomarker detection without particle enhancement.
Anti-IFNAR1 antibodies block Type I IFN signaling, reducing inflammation and immune cell activation in systemic lupus erythematosus.
A cell-based assay determines antibody sensitivity by adsorbing antibodies onto a solid-phase carrier and incubating them with target cells.
Organic electrochemical transistors functionalized with nanobodies enable label-free biosensing.
Acidic pH treatment dissociates protein A-IgG complexes to enable precise ligand binding and analyte quantification.